Post by Synendos Therapeutics AG

4,324 followers

Synendos Therapeutics AG Starts Phase 2 Trial in Generalized Anxiety Disorder (GAD). Read the full press release and follow our journey on our website: https://lnkd.in/eVcY5Psx #Innovation #SERI #LifeSciences #Neuropsychiatry #MentalHealth

Post content